Log In
BCIQ
Print this Print this
 

ReEBOV Antigen Rapid Test

  Manage Alerts
Collapse Summary General Information
Company Zalgen Labs LLC
DescriptionRapid chromatographic immunoassay that detects the VP40 antigen from Ebola viruses
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect Ebola Zaire virus
Regulatory Designation U.S. - Emergency Use Authorization (EUA) (Detect Ebola Zaire virus)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/22/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today